During the past decade, Medication Management, LLC conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 26 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 19 clinical trials were completed. i.e. 65.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medication Management, LLC" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Phathom Pharmaceuticals, Inc." with 3 trials sponsored and "R-Pharm International, LLC" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medication Management, LLC" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Medication Management, LLC" are "Rheumatoid Arthritis" (11 trials), "Systemic Lupus Erythematosus" (4 trials), "Arthritis, Rheumatoid" (3 trials), "Colorectal Cancer" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Medication Management, LLC" in a lesser frequency.

Most popular intervention types in "Medication Management, LLC" are "Drug" (46 trials), "Other" (6 trials), "Biological" (5 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Baricitinib" (3 trials), "Vonoprazan" (3 trials), "placebo" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medication Management, LLC" are 54 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medication Management, LLC". undefined are not yet recruiting, 13 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Medication Management, LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Medication Management, LLC, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".